Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 11Squamous Cell Carcinoma of Head and Neck 7Thyroid Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Salivary Gland Malignant Neoplasms 1Recurrence 1Precancerous Conditions 1Mouth Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Head and Neck Squamous Cell Cancer 1Head and Neck Neoplasms 1

Interventions

Carboplatin 2130-nm albumin-bound paclitaxel 2toripalimab 1sintilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Malignant Neoplasms × sintilimab × Head & Neck × Clear all
NCT05000892 2022-12-02

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
15 enrolled
Head & NeckOther neoplasm

Salivary Gland Malignant Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡